Cutler Group LP Iovance Biotherapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,397 shares of IOVA stock, worth $17,953. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,397

Previous 21,000 88.59%

Holding current value

$17,953

Previous $36,000 2.78%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$7.59 - $17.47 $18,193 - $41,875	2,397 New	2,397 $35,000
Q3 2023 Nov 07, 2023	BUY	$4.44 - $8.79 $2,220 - $4,395	500 Added 23.81%	2,600 $11,000
Q1 2023 May 01, 2023	SELL	$5.53 - $8.22 $16,208 - $24,092	-2,931 Reduced 58.26%	2,100 $12,000
Q4 2022 Feb 07, 2023	BUY	$5.62 - $10.0 $16,472 - $29,310	2,931 Added 139.57%	5,031 $32,000
Q2 2022 Aug 04, 2022	SELL	$6.38 - $18.33 $24,333 - $69,910	-3,814 Reduced 64.49%	2,100 $23,000
Q1 2022 Apr 14, 2022	SELL	$12.38 - $19.1 $225,179 - $347,409	-18,189 Reduced 75.46%	5,914 $98,000
Q4 2021 Jan 18, 2022	SELL	$16.55 - $27.63 $275,110 - $459,293	-16,623 Reduced 40.82%	24,103 $460,000
Q3 2021 Oct 26, 2021	BUY	$20.35 - $26.63 $495,176 - $647,987	24,333 Added 148.44%	40,726 $1 Million
Q2 2021 Jul 19, 2021	BUY	$16.33 - $33.07 $140,176 - $283,872	8,584 Added 109.92%	16,393 $426,000
Q3 2020 Oct 27, 2020	BUY	$27.75 - $36.3 $205,599 - $268,946	7,409 Added 1852.25%	7,809 $257,000
Q4 2019 Feb 06, 2020	BUY	$17.95 - $29.41 $7,180 - $11,764	400 New	400 $11,000
Q4 2018 Feb 05, 2019	SELL	$7.51 - $11.93 $37,550 - $59,650	-5,000 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$11.25 - $17.7 $56,250 - $88,500	5,000 New	5,000 $56,000
Q2 2018 Aug 10, 2018	SELL	$12.45 - $16.95 $1,195 - $1,627	-96 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$8.1 - $19.5 $7,322 - $17,628	-904 Reduced 90.4%	96 $1,000
Q3 2017 Oct 17, 2017	BUY	$4.45 - $8.55 $4,450 - $8,550	1,000	1,000 $7,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account